【研究前沿】ONC201治疗儿童和成人H3K27M突变型弥漫
CN-Healthcare,
研究背景 弥漫中线胶质瘤，H3K27M突变型（WHO-Ⅳ级）是一种预后极差的恶性肿瘤，此类肿瘤好发于儿童及青年。由于位置特殊，此类肿瘤一般难以通过手术切除。目前的标准治疗方式为放疗，剂量为54-60Gy。由于此类肿瘤大多为MGMT非甲基化类型，故TMZ治疗效…
Artificial intelligence matches cancer genotypes to patient phenotypes
Pediatric News ,
Precision medicine is driven by technologies such as rapid genome sequencing and artificial intelligence (AI), according to a…
Clinical Efficacy of Weekly ONC201 in Adult Recurrent Glioblastoma Published
Biospace,
) – Oncoceutics, Inc. announced that results from the second and third cohort of the Phase II trial for patients with recurrent…